121 related articles for article (PubMed ID: 1323651)
1. A comparison of the discriminative stimulus properties of delta 9-tetrahydrocannabinol and CP 55,940 in rats and rhesus monkeys.
Gold LH; Balster RL; Barrett RL; Britt DT; Martin BR
J Pharmacol Exp Ther; 1992 Aug; 262(2):479-86. PubMed ID: 1323651
[TBL] [Abstract][Full Text] [Related]
2. Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol.
Weissman A; Milne GM; Melvin LS
J Pharmacol Exp Ther; 1982 Nov; 223(2):516-23. PubMed ID: 6290642
[TBL] [Abstract][Full Text] [Related]
3. Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-hydroxy-delta 8-tetrahydrocannabinol in rats and pigeons.
Järbe TU; Hiltunen AJ; Mechoulam R
J Pharmacol Exp Ther; 1989 Sep; 250(3):1000-5. PubMed ID: 2550611
[TBL] [Abstract][Full Text] [Related]
4. Increasing the selectivity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol: complete substitution with methanandamide.
Alici T; Appel JB
Pharmacol Biochem Behav; 2004 Nov; 79(3):431-7. PubMed ID: 15582014
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm.
De Vry J; Jentzsch KR
Behav Pharmacol; 2003 Sep; 14(5-6):471-6. PubMed ID: 14501260
[TBL] [Abstract][Full Text] [Related]
6. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol.
Beardsley PM; Scimeca JA; Martin BR
J Pharmacol Exp Ther; 1987 May; 241(2):521-6. PubMed ID: 3033218
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
[TBL] [Abstract][Full Text] [Related]
8. Discriminative stimulus effects and receptor binding of enantiomeric pairs of cannabinoids in rats and pigeons; a comparison.
Järbe TU; Hiltunen AJ; Mathis DA; Hanŭs L; Breuer A; Mechoulam R
J Pharmacol Exp Ther; 1993 Feb; 264(2):561-9. PubMed ID: 8382275
[TBL] [Abstract][Full Text] [Related]
9. THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats.
Wakley AA; Craft RM
Behav Pharmacol; 2011 Sep; 22(5-6):489-97. PubMed ID: 21716095
[TBL] [Abstract][Full Text] [Related]
10. In vitro metabolism of (-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl) phenyl]-trans-4-(3-hydroxypropyl) cyclohexanol, a synthetic bicyclic cannabinoid analog.
Thomas BF; Martin BR
Drug Metab Dispos; 1990; 18(6):1046-54. PubMed ID: 1981511
[TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus effects of delta 9-tetrahydrocannabinol and delta 9-11-tetrahydrocannabinol in rats and rhesus monkeys.
Wiley JL; Barrett RL; Britt DT; Balster RL; Martin BR
Neuropharmacology; 1993 Apr; 32(4):359-65. PubMed ID: 8388551
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats.
Rowlett JK; Woolverton WL
J Pharmacol Exp Ther; 1997 Jan; 280(1):162-73. PubMed ID: 8996194
[TBL] [Abstract][Full Text] [Related]
13. Tolerance to the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol.
Wiley JL; Barrett RL; Balster RL; Martin BR
Behav Pharmacol; 1993 Dec; 4(6):581-585. PubMed ID: 11224227
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys.
Wiley JL; Huffman JW; Balster RL; Martin BR
Drug Alcohol Depend; 1995 Nov; 40(1):81-6. PubMed ID: 8746928
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol.
Zuardi AW; Finkelfarb E; Bueno OF; Musty RE; Karniol IG
Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):137-46. PubMed ID: 6261703
[TBL] [Abstract][Full Text] [Related]
16. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.
Lichtman AH; Cook SA; Martin BR
J Pharmacol Exp Ther; 1996 Feb; 276(2):585-93. PubMed ID: 8632325
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus effects of anandamide in rats.
Wiley J; Balster R; Martin B
Eur J Pharmacol; 1995 Mar; 276(1-2):49-54. PubMed ID: 7781695
[TBL] [Abstract][Full Text] [Related]
18. Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.
Solinas M; Zangen A; Thiriet N; Goldberg SR
Eur J Neurosci; 2004 Jun; 19(12):3183-92. PubMed ID: 15217374
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats.
Wiley JL; Barrett RL; Lowe J; Balster RL; Martin BR
Neuropharmacology; 1995 Jun; 34(6):669-76. PubMed ID: 7566504
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys.
Wiley JL; Lowe JA; Balster RL; Martin BR
J Pharmacol Exp Ther; 1995 Oct; 275(1):1-6. PubMed ID: 7562536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
